Papillary Thyroid Cancer
📧 Sign up to get email alerts when something new happens for Papillary Thyroid Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) [Phase 2]
Phase 2 basket study evaluating entrectinib in solid tumors harboring NTRK1/2/3, ROS1, or ALK gene rearrangements; the study is listed as Ac…
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer [Phase 2]
Phase 2 clinical trial evaluating PDR001 in combination therapy for radioiodine-refractory thyroid cancer is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: Oxidative Stress and Mitochondrial TERT in Papillary Thyroid Cancer.
A completed clinical trial by Istituto Auxologico Italiano investigating oxidative stress and mitochondrial TERT in papillary thyroid cancer…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers [Phase 1]
Phase 1 trial evaluating the combination of vemurafenib and copanlisib in radioiodine-refractory thyroid cancers has completed with results …
-
CLINICAL_TRIALS trial_result · 2025-02-03Clinical Trial Update: Regret Emotion After Thyroidectomy in Low-Risk Papillary Thyroid Cancer [NA]
The document describes a clinical trial evaluating regret emotion after thyroidectomy in patients with low-risk papillary thyroid cancer. It…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-01-30Clinical Trial Update: Radiofrequency Ablation of Papillary Thyroid Microcarcinoma [NA]
A completed clinical trial evaluating radiofrequency ablation for papillary thyroid microcarcinoma.
-
CLINICAL_TRIALS trial_result · 2024-12-27Clinical Trial Update: A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase 1/2 study evaluating CM24 in combination with nivolumab in adults with advanced…
-
CLINICAL_TRIALS trial_result · 2023-10-13Clinical Trial Update: A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer [Phase 3]
A Phase III clinical trial evaluating prophylactic central neck dissection in low-risk papillary thyroid cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Total Thyroidectomy With and Without Prophylactic Central Neck Lymph Node Dissection in People With Low-risk Papillary Thyroid Cancer [Phase 2]
Phase 2 trial investigating total thyroidectomy with or without prophylactic central neck lymph node dissection in low-risk papillary thyroi…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer [Phase 2]
Phase 2 adaptive TKI therapy trial in thyroid cancer was terminated; results posted previously.
-
CLINICAL_TRIALS trial_result · 2020-12-21Clinical Trial Update: Central Neck Dissection in Patients With Clinical Node Negative Thyroid Cancer [Phase 2]
Phase 2 clinical trial assessing central neck dissection in patients with clinically node-negative thyroid cancer has completed with results…
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: Percutaneous Ethanol Injection for Primary Papillary Thyroid Microcarcinoma [NA]
Clinical trial about percutaneous ethanol injection for primary papillary thyroid microcarcinoma; the study was terminated with results post…
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Sutent Adjunctive Treatment of Differentiated Thyroid Cancer [Phase 2]
Phase 2 trial evaluating Sutent as adjunctive therapy for differentiated thyroid cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2017-12-06Clinical Trial Update: BRAF V600E and Redifferentiation Therapy in Radioiodine-refractory Papillary Thyroid Cancer
A completed clinical trial investigated BRAF V600E–driven redifferentiation therapy for radioiodine-refractory papillary thyroid cancer.
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer [Phase 2]
A Phase 2 trial evaluating sunitinib malate for iodine-refractory recurrent or metastatic thyroid cancer has completed enrollment and posted…
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery [Phase 1]
Phase 1 study evaluating the combination of Iodine-131 and Pazopanib in patients with recurrent or metastatic thyroid cancer that cannot be …
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer [Phase 2]
This Phase 2 trial of sorafenib tosylate in children and young patients with relapsed or refractory rhabdomyosarcoma, Wilms tumor, hepatocel…
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131 [Phase 2]
Phase 2 clinical trial evaluating decitabine in iodine-refractory metastatic papillary or follicular thyroid cancer completed with results p…
-
CLINICAL_TRIALS trial_result · 2014-06-25Clinical Trial Update: Bortezomib in Treating Patients With Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy [Phase 2]
Phase 2 trial evaluating bortezomib in metastatic thyroid cancer patients non-responsive to radioactive iodine; study completed with results…
-
CLINICAL_TRIALS trial_result · 2014-05-06Clinical Trial Update: Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer [Phase 2]
Phase 2 trial of tanespimycin in patients with inoperable locoregionally advanced or metastatic thyroid cancer has completed with results po…
-
CLINICAL_TRIALS trial_result · 2014-01-16Clinical Trial Update: Sorafenib Tosylate in Treating Patients With Locally Advanced, Metastatic, or Locally Recurrent Thyroid Cancer [Phase 2]
Phase 2 trial of sorafenib tosylate in locally advanced, metastatic, or locally recurrent thyroid cancers was terminated.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Romidepsin in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Has Not Responded to Radioactive Iodine [Phase 2]
Phase 2 trial evaluating romidepsin in patients with recurrent and/or metastatic thyroid cancer not responding to radioactive iodine; result…
-
CLINICAL_TRIALS trial_result · 2012-01-13Clinical Trial Update: Prophylactic Central Neck Dissection for Papillary Thyroid Cancer [NA]
A completed clinical trial evaluating prophylactic central neck dissection in papillary thyroid cancer. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2011-10-13Clinical Trial Update: Study of XL281 in Adults With Solid Tumors [Phase 1]
Exelixis reports completion of a Phase 1 study of XL281 in adults with solid tumors, including non-small cell lung cancer, colorectal cancer…